Detailed Study Notes on Mutations in Noncoding Sequences

Mutations in Noncoding Sequences: Overview

• Noncoding sequence mutations are genetic changes that occur outside of the open reading frame (the protein-coding segments of DNA).

• While coding mutations alter the specific amino acid sequence of a protein, noncoding mutations can affect:

  • Whether the start of a gene is recognized by the cellular machinery.

  • The binding of transcription factors to DNA.

  • Upstream regulatory elements that control gene expression.

  • The splicing process of the RNA transcript.

Point Mutations in Promoter Sequences

• The Promoter and Transcription Initiation:

  • The promoter is located at the start of transcription and contains specific sequences like the TATA box and surrounding sequences.

  • Transcription factors bind to these sequences, which allows RNA polymerase to bind and begin generating the RNA sequence.

• Effects of Promoter Mutations:

  • A mutation in the promoter can prevent transcription factors from recognizing the site as the start of a gene.

  • If the transcription factors cannot bind, RNA polymerase will not be recruited, resulting in no transcription ($0$ RNA production).

  • Because transcription is the first step in protein synthesis, the absence of RNA means no protein is made.

  • Crucially, a mutation in the promoter can result in zero protein production even if the entire open reading frame of the gene is completely intact and functional.

Mutations in Splice Site Sequences

• The Splicing Process:

  • The cell identifies the "exon-intron boundary" (the end of an exon and the start of an intron).

  • It tracks along to find the start of the next exon.

  • Using specialized proteins, the cell recognizes the splice site and a "branch point" within the intron.

  • These proteins bring the two exons into close proximity and splice the intron out as a "lariat" type structure (a loop).

  • The final product is the upstream exon joined directly to the next exon.

• Consequences of Splice Site Mutations:

  • Mutations in the splice site or the branch point disrupt the enzyme's ability to facilitate correct splicing.

  • Intron Retention: The mutation causes an intron that should have been removed to remain in the mRNA sequence.

  • Exon Skipping: The mutation causes a cell to fail to recognize an exon, causing it to be spliced out along with the introns.

  • These mutations drive "abnormal" states of RNA splicing, which are distinct from physiological "alternative splicing" (a normal, intended cellular process).

• Genetic and Medical Impact:

  • Splicing defects result in "nonsense transcripts" where the RNA sequence no longer makes sense for translation.

  • Loss of exons results in the loss of large chunks of coding sequence, leading to protein instability and truncation mutations.

  • Nonsense-Mediated Decay (NMD): A surveillance mechanism where the cell recognizes the RNA as nonsense and degrades it before it can be loaded onto a ribosome.

  • Splicing mutations account for approximately $15\%$ of mutations causing human genetic disease, though this is likely an underestimation.

  • In specific conditions like mutations in NF and ATM (a cancer predisposition gene), splice site mutations account for up to $50\%$ of cases.

Mutations in Regulatory Sequences

• Upstream Regulatory Elements:

  • These sequences are located upstream of the gene and often "bend over" to interact with the start of the gene.

• Regulatory Functions: These elements control:

  • Level of Expression: Determining how much of the gene product is synthesized.

  • Timing of Expression: Determining when during development a gene is active.

  • Tissue Specificity: Determining which tissues (e.g., muscle cells vs. nerve cells) express the gene.

• Impact of Enhancer Mutations: If a mutation occurs in an upstream enhancer, the regulatory interaction fails, leading to problems where the gene is not expressed in the correct amount, at the right time, or in the appropriate tissue.

Point Mutations in Untranslated Regions (UTRs)

• Five Prime ($5'$) UTR: Located upstream from the start codon.

  • Contains "upstream open reading frames" (uORFs), which serve as decoy sequences to slow down the speed of protein production.

  • Contains complexes that help the transcript load onto ribosomes.

  • Involved in translational control and mRNA stability.

• Three Prime ($3'$) UTR: Located downstream from the stop codon.

  • Involved in translational control, subcellular localization (where the mRNA moves in the cell), and mRNA stability (how long the message lasts).

• Mutation Effects in UTRs: Mutations in these regions can lead to disease by altering:

  • The length of the UTR.

  • The function of open reading frames (uORFs).

  • Ribosome recognition sites.

  • The polyadenylation signal and termination codons.

  • The overall secondary structure of the RNA, affecting how much protein is made and how quickly it is synthesized.